Company intelligence / Profile preview

Dermakor

Anyang-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

Dermakor is a South Korean biotechnology company specializing in the development and manufacture of aesthetic and therapeutic medical products. The company focuses on advanced biomaterials, particularly hyaluronic acid-based dermal fillers and mesotherapy solutions designed for anti-aging and skin rejuvenation. Their product portfolio includes the Florice and Teru brands, which utilize proprietary cross-linking technologies to enhance safety and longevity. Beyond aesthetics, Dermakor explores therapeutic applications for its biomaterial platforms in areas such as orthopedics and tissue regeneration.

Therapeutic areas: DermatologyRheumatologyMetabolic Disorders
Modalities: DeviceSmall moleculePeptidesBiologic
Industry: Biotech

Beyond the preview

Go deeper on Dermakor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermakor.

Explore the full profile